Blueprint Medicines Corporation (BPMC)
NASDAQ: BPMC · IEX Real-Time Price · USD
114.36
-6.14 (-5.10%)
At close: Jul 17, 2024, 4:00 PM
113.10
-1.26 (-1.10%)
After-hours: Jul 17, 2024, 7:15 PM EDT

Blueprint Medicines Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018 - 2013
Net Income
-288.29-506.98-557.52-644.09313.88-347.69
Upgrade
Depreciation & Amortization
22.120.7720.112.7912.3510.25
Upgrade
Share-Based Compensation
93.792.6798.9791.6375.5354.65
Upgrade
Other Operating Activities
-242.92-43.31-63.83241.02-14.724.78
Upgrade
Operating Cash Flow
-415.4-436.85-502.28-298.65387.04-278.02
Upgrade
Capital Expenditures
-14.58-16.06-8.92-3.09-3.16-14.01
Upgrade
Acquisitions
000-258.1500
Upgrade
Change in Investments
192.96290.1-140.3335.38-431.09-2.45
Upgrade
Other Investing Activities
---0.29---
Upgrade
Investing Cash Flow
178.38274.04-149.54-225.86-434.25-16.47
Upgrade
Share Issuance / Repurchase
88.6721.348.250.72617.76340.75
Upgrade
Debt Issued / Paid
97.5697.93137.79000
Upgrade
Other Financing Activities
-0.04-0.04415.83---0.12
Upgrade
Financing Cash Flow
186.19119.23561.8150.72617.76340.64
Upgrade
Exchange Rate Effect
-0.140.2-0.21-0.89-0.350.02
Upgrade
Net Cash Flow
-50.83-43.58-90.01-473.8570.5546.16
Upgrade
Free Cash Flow
-429.98-452.91-511.2-301.74383.88-292.03
Upgrade
Free Cash Flow Margin
-152.36%-181.61%-250.54%-167.56%48.36%-439.06%
Upgrade
Free Cash Flow Per Share
-6.98-7.48-8.57-5.167.04-6.11
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).